back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-03 16:43 Tx date 2022-12-30 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Snow, Anthony Yung
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+25,644 vol |
25,644 | |
| Filed 2023-01-03 16:39 Tx date 2022-08-12 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Snow, Anthony Yung
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-20 13:47 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+36,340 vol |
36,340 | |
| Filed 2022-05-20 13:46 Tx date 2022-05-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-19 22:01 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-19 21:59 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-19 21:57 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-19 21:55 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-19 21:48 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ritchie, Mary C.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
35,152 | |
| Filed 2022-04-02 16:07 Tx date 2022-03-31 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,973
+6,800 vol $1.47 each |
123,786 | |
| Filed 2022-03-30 09:39 Tx date 2022-03-30 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-8,792 vol |
192,822 | |
| Filed 2022-01-05 17:12 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+25,500 vol |
33,000 | |
| Filed 2022-01-05 17:10 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,000 vol |
33,625 | |
| Filed 2022-01-05 17:06 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+18,000 vol |
42,000 | |
| Filed 2022-01-05 17:04 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Berardelli, Luigi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
67,000 | |
| Filed 2022-01-05 17:02 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+18,000 vol |
42,000 | |
| Filed 2022-01-05 17:01 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
113,720 | |
| Filed 2022-01-05 16:59 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+18,000 vol |
42,000 | |
| Filed 2022-01-05 16:57 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
201,614 | |
| Filed 2022-01-05 16:53 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Burkett, Mary-Jane Eleanor
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+25,500 vol |
49,500 |